1.
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-...
by Cahn, Pedro, Dr
The Lancet infectious diseases, 2014, Vol.14 (7), p.572-580
2.
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
by Molina, Jean-Michel, Dr, Prof
The Lancet (British edition), 2011, Vol.378 (9787), p.238-246
3.
The HIV care continuum in Latin America: challenges and opportunities
by Piñeirúa, Alicia, MD
The Lancet infectious diseases, 2015, Vol.15 (7), p.833-839
Filter electronic articles 3 Hits
Remove Filters
